Your browser doesn't support javascript.
loading
Incorporating Erlotinib or Irinotecan Plus Cisplatin into Chemoradiotherapy for Stage III Non-small Cell Lung Cancer According to EGFR Mutation Status.
Lee, Youngjoo; Han, Ji-Youn; Moon, Sung Ho; Nam, Byung-Ho; Lim, Kun Young; Lee, Geon Kook; Kim, Heung Tae; Yun, Tak; An, Hye Jin; Lee, Jin Soo.
Afiliação
  • Lee Y; Center for Lung Cancer, National Cancer Center, Goyang, Korea.
  • Han JY; Center for Lung Cancer, National Cancer Center, Goyang, Korea.
  • Moon SH; Center for Proton Therapy, National Cancer Center, Goyang, Korea.
  • Nam BH; Center for Clinical Trials, National Cancer Center, Goyang, Korea.
  • Lim KY; Center for Lung Cancer, National Cancer Center, Goyang, Korea.
  • Lee GK; Center for Lung Cancer, National Cancer Center, Goyang, Korea.
  • Kim HT; Center for Lung Cancer, National Cancer Center, Goyang, Korea.
  • Yun T; Center for Lung Cancer, National Cancer Center, Goyang, Korea.
  • An HJ; Center for Lung Cancer, National Cancer Center, Goyang, Korea.
  • Lee JS; Center for Lung Cancer, National Cancer Center, Goyang, Korea.
Cancer Res Treat ; 49(4): 981-989, 2017 Oct.
Article em En | MEDLINE | ID: mdl-28111430
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Pulmonar de Células não Pequenas / Receptores ErbB / Neoplasias Pulmonares / Mutação Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Pulmonar de Células não Pequenas / Receptores ErbB / Neoplasias Pulmonares / Mutação Idioma: En Ano de publicação: 2017 Tipo de documento: Article